首页 | 本学科首页   官方微博 | 高级检索  
     


53 A phase I study of epidermal growth factor receptor (EGFR) antibody EMD 72000 in combination with paclitaxel (P) in patients (pts) with EGFR-positive advanced non-small cell lung cancer (NSCLC)
Affiliation:1. National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency (NSTDA), 113 Thailand Science Park, Phahonyothin Road, Khlong Nueng, Khlong Luang, Pathum Thani 12120, Thailand;2. Center of Excellence for Shrimp Molecular Biology and Biotechnology (CENTEX SHRIMP), Faculty of Science, Mahidol University, 272 Rama 6 Road, Thung Phaya Thai, Rachathewi, Bangkok 10400, Thailand;3. Department of Integrative Biology, School of Bio-Sciences and Technology, VIT University, Vellore 632 014, Tamilnadu, India;4. School of Science, Walailak University, 222 Thaiburi, Thasala District, Nakhon Si Thammarat 80161, Thailand;5. Department of Marine and Coastal Resources, Ministry of Natural Resources and Environment, 120 Moo 3 Ratthaprasasanabhakti Building Chaeng Wattana Road, Laksi, Bangkok, Thailand;1. Núcleo de Genética Humana e Molecular, Departamento de Ciências Biológicas, Universidade Federal do Espírito Santo, Espírito Santo, Brazil;2. Representante da Universidade Federal do Espírito Santo no Comitê de Publicação do Projeto Elsa, Universidade Federal do Espírito Santo, Espírito Santo, Brazil;3. Instituto de Bioquímica Médica Leopoldo De Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号